Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) EBIT Margin (2019 - 2025)

Historic EBIT Margin for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to 15.96%.

  • Legend Biotech's EBIT Margin rose 279600.0% to 15.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 73.8%, marking a year-over-year increase of 159500.0%. This contributed to the annual value of 23412.57% for FY2024, which is 95085900.0% up from last year.
  • According to the latest figures from Q3 2025, Legend Biotech's EBIT Margin is 15.96%, which was up 279600.0% from 132.48% recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's EBIT Margin ranged from a high of 596.51% in Q2 2022 and a low of 97962.57% during Q1 2021
  • For the 5-year period, Legend Biotech's EBIT Margin averaged around 4921.94%, with its median value being 215.62% (2024).
  • In the last 5 years, Legend Biotech's EBIT Margin tumbled by -984513400bps in 2021 and then surged by 982082500bps in 2022.
  • Legend Biotech's EBIT Margin (Quarter) stood at 230.36% in 2021, then soared by 72bps to 395.35% in 2022, then crashed by -85bps to 57.62% in 2023, then increased by 28bps to 73.77% in 2024, then tumbled by -122bps to 15.96% in 2025.
  • Its EBIT Margin was 15.96% in Q3 2025, compared to 132.48% in Q2 2025 and 147.38% in Q1 2025.